A
Anna Niarakis
Researcher at University of Paris
Publications - 46
Citations - 931
Anna Niarakis is an academic researcher from University of Paris. The author has contributed to research in topics: Computer science & Biology. The author has an hindex of 11, co-authored 32 publications receiving 678 citations. Previous affiliations of Anna Niarakis include École Normale Supérieure & RMIT University.
Papers
More filters
Journal ArticleDOI
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Spyridon Mourtas,Mara Canovi,Cristiano Zona,Dario Aurilia,Anna Niarakis,Barbara La Ferla,Mario Salmona,Francesco Nicotra,Marco Gobbi,Sophia G. Antimisiaris +9 more
TL;DR: The preparation and characterization of new nanoparticles with a very high affinity for Aβ1-42 fibrils are described, to be exploited as vectors for the targeted delivery of new diagnostic and therapeutic molecules for AD.
Journal ArticleDOI
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.
Mark Taylor,Susan Moore,Spyridon Mourtas,Anna Niarakis,Francesca Re,Cristiano Zona,Barbara La Ferla,Francesco Nicotra,Massimo Masserini,Sophia G. Antimisiaris,Maria Gregori,David Allsop +11 more
TL;DR: Of the three forms of curcumin liposomes tested, the click-curcumin type was by far the most effective and could be further developed as a novel treatment for Alzheimer's disease.
Journal ArticleDOI
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Eleni Markoutsa,Georgios Pampalakis,Anna Niarakis,Ignacio A. Romero,Babette B. Weksler,Pierre-Olivier Couraud,Sophia G. Antimisiaris +6 more
TL;DR: Experimental results reveal that hCMEC/D3 cells are good models for in vitro screening of BBB-targeting nanoparticulate drug delivery systems, and co-decoration with a second ligand slightly decreases OX-26-decorated vesicle uptake, but not transcytosis, proving that the biotin-streptavidin technique can be applied for the generation of dual- targeting nanoliposomes.
Journal ArticleDOI
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.
Marek Ostaszewski,Alexander Mazein,Alexander Mazein,Marc Gillespie,Marc Gillespie,Inna Kuperstein,Anna Niarakis,Henning Hermjakob,Alexander R. Pico,Egon Willighagen,Chris T. Evelo,Jan Hasenauer,Jan Hasenauer,Falk Schreiber,Falk Schreiber,Andreas Dräger,Emek Demir,Olaf Wolkenhauer,Olaf Wolkenhauer,Laura I. Furlong,Emmanuel Barillot,Joaquín Dopazo,Aurelio Orta-Resendiz,Aurelio Orta-Resendiz,Francesco Messina,Alfonso Valencia,Alfonso Valencia,Akira Funahashi,Hiroaki Kitano,Charles Auffray,Rudi Balling,Reinhard Schneider +31 more
TL;DR: Researchers around the world join forces to reconstruct the molecular processes of the virus-host interactions aiming to combat the cause of the ongoing pandemic.
Journal ArticleDOI
Community-driven roadmap for integrated disease maps.
Marek Ostaszewski,Stephan Gebel,Inna Kuperstein,Alexander Mazein,Andrei Zinovyev,Ugur Dogrusoz,Jan Hasenauer,Ronan M. T. Fleming,Nicolas Le Novère,Piotr Gawron,Thomas Ligon,Anna Niarakis,David P. Nickerson,Daniel Weindl,Rudi Balling,Emmanuel Barillot,Charles Auffray,Reinhard Schneider +17 more
TL;DR: This article summarizes the 2nd Disease Maps Community meeting, highlighting its important topics and outcomes and outlines milestones on the roadmap for the future development of disease maps, including creating and maintaining standardized disease maps.